Type 2 Diabetes Trial, Recruiting (NCT07641361)

Type 2 Diabetes Trial, Recruiting NCT07641361 Sponsor: State University of New York at Buffalo Condition: Type 2 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT07641361 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 2 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults between 18 and 60 years of age
People who have recently been prescribed a GLP-1RA medication (a type of diabetes/weight management injection or tablet) within the past week
People who are fluent in English
People who are willing to follow the study requirements for the duration of the trial

Who may not be able to join:

People under 18 or over 60 years of age
People who are not currently taking a GLP-1RA medication
People who have already been taking a GLP-1RA medication for longer than one week
People who are not fluent in English
People who are pregnant or planning to become pregnant during the study period
People who are not willing or able to follow the study requirements
People who have a cardiac implant (such as a pacemaker or similar device fitted in or around the heart)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07641361

Sponsor: State University of New York at Buffalo

Phase: Not Applicable

Status: Recruiting

Condition: Type 2 Diabetes

More information: https://clinicaltrials.gov/study/NCT07641361

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults between 18 and 60 years of age
People who have recently been prescribed a GLP-1RA medication (a type of diabetes/weight management injection or tablet) within the past week
People who are fluent in English
People who are willing to follow the study requirements for the duration of the trial

Who may not be able to join:

People under 18 or over 60 years of age
People who are not currently taking a GLP-1RA medication
People who have already been taking a GLP-1RA medication for longer than one week
People who are not fluent in English
People who are pregnant or planning to become pregnant during the study period
People who are not willing or able to follow the study requirements
People who have a cardiac implant (such as a pacemaker or similar device fitted in or around the heart)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

State University of New York at Buffalo

Registry

ClinicalTrials.gov

Start date

15 June 2026

Est. completion

1 February 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Acceptability of hydration plus; Feasibility of Intervention; Change in physiological hydration score; Change in perceived hydration level

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov